BIOINVENT INTL NEW (BOVNF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 1 61 sessions, June 10, 2024 to June 10, 2025
- Largest daily move
- -30% close of June 10, 2025
- 1-year change
- -30% closing prices, June 10, 2024 to June 10, 2025
- 5-year change
- -6% closing prices, June 10, 2020 to June 10, 2025
Company Description
BIOINVENT INTL NEW (OTC: BOVNF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $216.4M.
BOVNF has declined 30.0% over the past year. The last closing price was $3.29.
This page collects what Stock Titan holds for BOVNF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BIOINVENT INTL NEW (BOVNF) closed at $3.29 on June 10, 2025. Over the past 12 months, the price has lost 30.0%.
BOVNF Metrics & Rankings
Price returns through June 10, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
BIOINVENT INTL NEW has 8 recent news articles. Key topics include clinical trial, conferences, earnings. View all BOVNF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in BIOINVENT INTL NEW (BOVNF) currently stands at 12 shares. Since July 2026, short interest has decreased by 40.0%. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for BIOINVENT INTL NEW (BOVNF) currently stands at 1000.0 days, up 16566.5% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 19899.8% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 5.0 to 1000.0 days.
BOVNF Company Profile & Sector Positioning
BIOINVENT INTL NEW (BOVNF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BOVNF often look at related companies in the same sector, including SILENCE THERAPEUTICS (SLNCF), ORYZON GENOMICS SA (ORYZF), NERVGEN PHARMA CORP (NGENF), HANSA MEDICAL AB (HNSBF), and ADOCIA (ADOCY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BOVNF's relative position within its industry.